Most consulting firms cover broad CMC areas.
We focus exclusively on process-related impurity ELISAs.

That focus allows us to:

• Diagnose root causes faster

• Design smarter optimization strategies

• Anticipate regulatory expectations

• Translate scientific findings into defensible validation data

A Risk-Based, Mechanistic Approach

We do not treat ELISAs as checklist exercises.

Our approach integrates:

• Antibody-antigen binding science

• Manufacturing process knowledge

• Matrix interaction understanding

• Statistical modeling

• Regulatory precedent

We help teams design assays that are not only functional — but defensible.

We partner with:

• Analytical Development

• MSAT

• QC

• Regulatory Affairs

• CDMOs

• Biotech startups preparing for IND/BLA

If you require assistance developing or troubleshooting your ELISA, please fill our and complete the form below!